Abstract
Considering public moral attitudes is a hallmark of the anticipatory governance of emerging biotechnologies, such as heritable human genome editing. However, such anticipatory governance often overlooks that future morality is open to change and that future generations may perform different moral assessments on the very biotechnologies we are trying to govern in the present. In this article, we identify an ‘anticipatory gap’ that has not been sufficiently addressed in the discussion on the public governance of heritable genome editing, namely, uncertainty about the moral visions of future generations about the emerging applications that we are currently attempting to govern now. This paper motivates the relevance of this anticipatory gap, identifying the challenges it generates and offering various recommendations so that moral uncertainty does not lead to governance paralysis with regard to human germline genome editing.
Funder
Fulbright Association
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Ministerio de Universidades
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundación Banco Sabadell
H2020 European Research Council
'la Caixa' Foundation
Reference61 articles.
1. Ethics and Technology ‘in the Making’: An Essay on the Challenge of Nanoethics
2. What is an emerging technology?;Rotolo;Research Policy,2015
3. Brey PAE . Ethics of emerging technology. In: Hansson SO , ed. The Ethics of Technology: Methods and Approaches. London: Rowman & Littlefield International, 2017: 175–91.
4. Henderson H . CRISPR clinical trials: a 2024 update [Innovative Genomics]. 2024. Available: https://innovativegenomics.org/news/crispr-clinical-trials-2024/
5. CRISPR 2.0: a new wave of gene editors heads for clinical trials;Ledford;Nature,2023
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献